➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Johnson and Johnson
Harvard Business School
Medtronic
Dow

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 8,092,315

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,092,315
Title:Methods and apparatus to indicate impact of an object
Abstract: In one embodiment, an apparatus includes a substrate layer having a first and second sides, and at least one thermochromic compound layer to generate a set of temporary marks. The set of temporary marks is configured to include a first temporary mark at a first impact location associated with a first impact to a surface of a first object by a second object, and subsequent temporary marks at subsequent impact locations associated with subsequent impacts to the surface of the first object. The thermochromic compound layer can be in direct contact with the second object during the first impact, and is configured to enable the first temporary mark to fade throughout a fading period accommodative of the subsequent impacts, and to remain distinguishable throughout the fading period from the subsequent temporary marks. Other examples, embodiments and related methods are described and claimed herein.
Inventor(s): Swartz; Greg J. (Anthem, AZ), Kenville; Peter J. (Everett, WA), Tighe; Laurence E. (Seattle, WA)
Assignee: Karsten Manufacturing Corporation (Phoenix, AZ)
Application Number:11/735,316
Patent Claims:see list of patent claims

Details for Patent 8,092,315

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Karsten Manufacturing Corporation (Phoenix, AZ) 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Johnson and Johnson
Baxter
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.